Anti-tumor vaccine efficacy depends on adjuvant type and associates with induced IgG subclass and glycosylation profiles
Lehrian S, Wasynczuk A, Petry J, Guderian M, Nouta J, Buhre J, Lunding H, Köcher P, Schumacher H, Dühring L, Kurwahn K, Manzhula K, Manz R, Bartsch Y, Wuhrer M, Ehlers M

